A low-cost assay to detect multiple early-stage cancers from just one millilitre of blood for better decisions on referral in primary care, save lives and to help pharma access patients earlier.
Following the success of three accelerator programmes we have clinical validation of this assay and more novel IP in the pipeline for wider disease indications and metastatic therapy, all developed on non-diluting funds.
|
|
|
|
|
1-10 employees
View all MetaGuideX Ltd employees
|
|
|
Biotechnology
|
|
|
Gipsy Lane, Bioinnovation Hub, Oxford, Oxfordshire OX3 0BP, GB
|
|
|
2020
|
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.